Alteration of Intestinal Microbiota and Hydrogen Sulfide Metabolism in Patients with Hashimoto's Thyroiditis

Overview

Journal J Healthc Eng

Specialty Biomedical Engineering

Date 2023 Jul 20

PMID 37469789

Authors

Shangqing Zhang

Yan Chi

Hongfang Jin

Xiuli Wang

Xue Zhao

Ying Gao

Junqing Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: To analyze the intestinal microbiota and H2S levels in patients with HT.

Methods: Twenty euthyroid HT patients and twenty healthy control individuals were recruited. Fecal samples were collected, and the microbiota was examined using 16S RNA gene sequencing. We also collected serum samples to examine the H2S levels.

Results: Compared with patients with HT, the ACE and Chao indices were significantly lower in healthy controls (=0.04, 0.03, respectively). The microbial composition of the HT group differed significantly from that of the healthy group. We observed a significant increase in the proportions of , , , and in patients with HT ( < 0.05). Linear discriminant analysis and effect size analysis also revealed that and were enriched in patients with HT. Additionally, patients with HT had significantly lower H2S levels than healthy controls ( < 0.005). The enrichment of H2S anabolism was linked to the alteration of intestinal microbiota in patients with HT.

Conclusion: We demonstrated that patients with HT have aberrant intestinal microbiome and that H2S anabolism may contribute to HT pathogenesis.

Citing Articles

Retracted: Alteration of Intestinal Microbiota and Hydrogen Sulfide Metabolism in Patients with Hashimoto's Thyroiditis.

Healthcare Engineering J J Healthc Eng. 2023; 2023:9837045.

PMID: 38078163 PMC: 10699901. DOI: 10.1155/2023/9837045.

References

Zhao F, Feng J, Li J, Zhao L, Liu Y, Chen H . Alterations of the Gut Microbiota in Hashimoto's Thyroiditis Patients. Thyroid. 2018; 28(2):175-186. DOI: 10.1089/thy.2017.0395. View

Shen X, Carlstrom M, Borniquel S, Jadert C, Kevil C, Lundberg J . Microbial regulation of host hydrogen sulfide bioavailability and metabolism. Free Radic Biol Med. 2013; 60:195-200. PMC: 4077044. DOI: 10.1016/j.freeradbiomed.2013.02.024. View

Gong B, Wang C, Meng F, Wang H, Song B, Yang Y . Association Between Gut Microbiota and Autoimmune Thyroid Disease: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021; 12:774362. PMC: 8635774. DOI: 10.3389/fendo.2021.774362. View

Honda K, Littman D . The microbiota in adaptive immune homeostasis and disease. Nature. 2016; 535(7610):75-84. DOI: 10.1038/nature18848. View

Blachier F, Beaumont M, Kim E . Cysteine-derived hydrogen sulfide and gut health: a matter of endogenous or bacterial origin. Curr Opin Clin Nutr Metab Care. 2018; 22(1):68-75. DOI: 10.1097/MCO.0000000000000526. View

Cornejo-Pareja I, Ruiz-Limon P, Gomez-Perez A, Molina-Vega M, Moreno-Indias I, Tinahones F . Differential Microbial Pattern Description in Subjects with Autoimmune-Based Thyroid Diseases: A Pilot Study. J Pers Med. 2020; 10(4). PMC: 7712884. DOI: 10.3390/jpm10040192. View

Antonelli A, Ferrari S, Corrado A, Di Domenicantonio A, Fallahi P . Autoimmune thyroid disorders. Autoimmun Rev. 2014; 14(2):174-80. DOI: 10.1016/j.autrev.2014.10.016. View

Vitales-Noyola M, Ramos-Levi A, Martinez-Hernandez R, Serrano-Somavilla A, Sampedro-Nunez M, Gonzalez-Amaro R . Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders. Endocrine. 2017; 57(3):409-417. DOI: 10.1007/s12020-017-1361-y. View

Weetman A . Autoimmune thyroid disease. Autoimmunity. 2004; 37(4):337-40. DOI: 10.1080/08916930410001705394. View

10.

Liu X, Mao B, Gu J, Wu J, Cui S, Wang G . -a new functional genus with potential probiotic properties?. Gut Microbes. 2021; 13(1):1-21. PMC: 7872077. DOI: 10.1080/19490976.2021.1875796. View

11.

Cayres L, de Salis L, Rodrigues G, van Helvoort Lengert A, Biondi A, Sargentini L . Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis. Front Immunol. 2021; 12:579140. PMC: 7973118. DOI: 10.3389/fimmu.2021.579140. View

12.

Prummel M, Strieder T, Wiersinga W . The environment and autoimmune thyroid diseases. Eur J Endocrinol. 2004; 150(5):605-18. DOI: 10.1530/eje.0.1500605. View

13.

Whiteman M, Haigh R, Tarr J, Gooding K, Shore A, Winyard P . Detection of hydrogen sulfide in plasma and knee-joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation. Ann N Y Acad Sci. 2010; 1203:146-50. DOI: 10.1111/j.1749-6632.2010.05556.x. View

14.

Kushkevych I, Cejnar J, Treml J, Dordevic D, Kollar P, Vitezova M . Recent Advances in Metabolic Pathways of Sulfate Reduction in Intestinal Bacteria. Cells. 2020; 9(3). PMC: 7140700. DOI: 10.3390/cells9030698. View

15.

Hasham A, Tomer Y . Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol Res. 2012; 54(1-3):204-13. PMC: 3601048. DOI: 10.1007/s12026-012-8302-x. View

16.

Kim C, Park J, Kim M . Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation. Immune Netw. 2015; 14(6):277-88. PMC: 4275385. DOI: 10.4110/in.2014.14.6.277. View

17.

Wang R . Shared signaling pathways among gasotransmitters. Proc Natl Acad Sci U S A. 2012; 109(23):8801-2. PMC: 3384202. DOI: 10.1073/pnas.1206646109. View

18.

Caturegli P, De Remigis A, Rose N . Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014; 13(4-5):391-7. DOI: 10.1016/j.autrev.2014.01.007. View

19.

Dilek N, Papapetropoulos A, Toliver-Kinsky T, Szabo C . Hydrogen sulfide: An endogenous regulator of the immune system. Pharmacol Res. 2020; 161:105119. DOI: 10.1016/j.phrs.2020.105119. View

20.

Reygner J, Charrueau C, Delannoy J, Mayeur C, Robert V, Cuinat C . Freeze-dried fecal samples are biologically active after long-lasting storage and suited to fecal microbiota transplantation in a preclinical murine model of infection. Gut Microbes. 2020; 11(5):1405-1422. PMC: 7524285. DOI: 10.1080/19490976.2020.1759489. View